Display Settings:

Format

Send to:

Choose Destination
    J Hepatol. 2009 Nov;51(5):967-9. Epub 2009 Jul 10.

    Acute hepatitis due to brivudin: a case report.

    Source

    General Internal Medicine, University Hospitals, Geneva, Switzerland.

    Abstract

    BACKGROUND/AIMS:

    Brivudin is licensed in several European countries for the treatment of herpetic infections, and is considered safe (approximately 1% of patients with transient elevation of liver enzymes) in large multicenter trials.

    METHODS:

    We report a case of acute brivudin hepatitis documented with a liver biopsy in detail.

    RESULTS:

    Liver biopsy demonstrated acute liver injury with a predominant cytolytic pattern and features suggestive of a drug-induced immunoallergic hepatitis. Elevated ALT levels returned to normal within weeks.

    CONCLUSIONS:

    This is the first published case of acute immunoallergic hepatitis due to brivudin.

    PMID:
    19692139
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk